FBXO45 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance
Normal-vs-Primary 4.30369999970814E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Stage1
1.773890E-02
Normal-vs-Stage2
2.62399999995111E-06
Normal-vs-Stage3
2.208800E-01
Normal-vs-Stage4
4.245900E-02
Stage1-vs-Stage2
3.378800E-01
Stage1-vs-Stage3
9.063100E-03
Stage1-vs-Stage4
2.446200E-01
Stage2-vs-Stage3
1.158240E-01
Stage2-vs-Stage4
6.157600E-02
Stage3-vs-Stage4
9.580600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Caucasian
8.88660000031294E-07
Normal-vs-AfricanAmerican
1.862840E-01
Normal-vs-Asian
6.064600E-01
Caucasian-vs-AfricanAmerican
7.670600E-01
Caucasian-vs-Asian
2.274400E-01
AfricanAmerican-vs-Asian
1.939550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Male
7.80470000000255E-05
Normal-vs-Female
5.98569999999965E-05
Male-vs-Female
7.355800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Age(21-40Yrs)
8.661700E-02
Normal-vs-Age(41-60Yrs)
3.88719999999676E-05
Normal-vs-Age(61-80Yrs)
4.431500E-04
Normal-vs-Age(81-100Yrs)
2.241800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.827400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.630400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.436000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.147800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.770600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.731000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Non Drinker
3.152400E-01
Normal-vs-Daily Drinker
3.961800E-01
Normal-vs-Weekly Drinker
1.000760E-01
Normal-vs-Occasional Drinker
1.145790E-02
Normal-vs-Social Drinker
2.844400E-02
Non Drinker-vs-Daily Drinker
9.437000E-01
Non Drinker-vs-Weekly Drinker
6.039600E-01
Non Drinker-vs-Occasional Drinker
3.478000E-02
Non Drinker-vs-Social Drinker
1.238000E-01
Daily Drinker-vs-Weekly Drinker
5.510200E-01
Daily Drinker-vs-Occasional Drinker
3.303700E-02
Daily Drinker-vs-Social Drinker
1.193170E-01
Weekly Drinker-vs-Occasional Drinker
6.756000E-02
Weekly Drinker-vs-Social Drinker
3.133000E-01
Occasional Drinker-vs-Social Drinker
2.810000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions
Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade)
Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Grade 1
2.475800E-01
Normal-vs-Grade 2
1.116030E-01
Normal-vs-Grade 3
7.768200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.907800E-02
Grade 1-vs-Grade 3
1.037880E-02
Grade 1-vs-Grade 4
2.475800E-01
Grade 2-vs-Grade 3
1.646410E-01
Grade 2-vs-Grade 4
1.116030E-01
Grade 3-vs-Grade 4
7.768200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Diabetic
9.929700E-02
Normal-vs-NonDiabetic
8.11430000000612E-05
Diabetic-vs-NonDiabetic
3.712200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Pancreatitis
4.399700E-02
Normal-vs-NoPancreatitis
7.62720000000439E-05
Pancreatitis-vs-NoPancreatitis
8.306000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions
N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes
N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-N0
4.214700E-04
Normal-vs-N1
2.00839999999758E-05
N0-vs-N1
7.249800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-TP53-Mutant
8.68590000036029E-07
Normal-vs-TP53-NonMutant
1.562960E-03
TP53-Mutant-vs-TP53-NonMutant
1.627980E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap